Prevention of post-contrast kidney injury in patients with cancer

Emanuele Grassedonio, Lorena Incorvaia, Marco Guarneri, Fabio Guagnini, Massimo Midiri

Article Type

Review

Published

This article aims to review the literature on mechanisms of post-contrast acute kidney injury, risk factors and available strategies to control the risk in patients with cancer and to report the authors’ experience with managing post-contrast acute kidney injury risk in oncology.

Read more

Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune-checkpoint inhibitors

Darren MC Poon, Kuen Chan, Angus Kwong-Chuen Leung, Brian Ng, Foon-Yiu Cheung, Steven Wai-Kwan Siu, Hong Kong Society of Uro-Oncology

Article Type

Original Research

Published

In this study, the authors investigated the toxicity and efficacy of cabozantinib in Chinese patients who progressed on VEGFR TKIs and/or ICIs in real-life clinical practice.

Read more

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet

Muhammed Ahmed Elhadedy, Ghada El-Kannishy, Ayman F Refaie, Hussein A Sheashaa, Ahmed Halawa

Article Type

Original Research

Published

This research compares the effectiveness of parathyroidectomy versus cinacalcet for the treatment of secondary hyperparathyroidism, assessing the short-term and long-term impact on renal allograft survival and the chronic
kidney disease and mineral bone disorder profile following transplantation.

Read more

Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review

Xenophon Kassianides BSc (Hons), MBBS, MRCP(UK), Sunil Bhandari MBChB, MRCP, FRCP, PhD, M Clin Edu, FHEA

Article Type

Review

Published

This review focues on the links between iron and phosphate metabolism, the most recent comparative studies between third-generation i.v. iron compounds, the important role of fibroblast growth factor 23 (FGF23), and the impact of hypophosphataemia on the patient. This review also presents an algorithm that can be used in patients requiring i.v. iron in anticipation of potential hypophosphataemia.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.